Spring Creek Capital LLC / TREUR
Spring Creek Capital LLC’s Trillium Therapeutics Inc Position
Does Spring Creek Capital LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 1.33M shares worth $23M in Q3 2021; the fund’s latest 13F (Q3 2023) no longer reports it.
Position Value
$23M
Q3 2021
Shares
1.33M
% of Portfolio
+1.14%
Quarters Held
1
position exited
Position History TREUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 1.33M | $23M | +1.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Spring Creek Capital LLC’s full portfolio or all institutional holders of TREUR.